[go: up one dir, main page]

EE200300515A - Arüülsulfoonamiidid kui viirusevastased ained - Google Patents

Arüülsulfoonamiidid kui viirusevastased ained

Info

Publication number
EE200300515A
EE200300515A EEP200300515A EEP200300515A EE200300515A EE 200300515 A EE200300515 A EE 200300515A EE P200300515 A EEP200300515 A EE P200300515A EE P200300515 A EEP200300515 A EE P200300515A EE 200300515 A EE200300515 A EE 200300515A
Authority
EE
Estonia
Prior art keywords
arylsulfonamides
antiviral agents
antiviral
agents
Prior art date
Application number
EEP200300515A
Other languages
English (en)
Inventor
Wunberg Tobias
Bender Wolfgang
Eckenberg Peter
Hallenberger Sabine
Henninger Kerstin
Keldenich J�Rg
Kern Armin
Raddatz Siegfried
Reefschl�ger J�rgen
Schmidt Gunter
Zimmermann Holger
Zumpe Franz
Radtke Martin
Original Assignee
Bayer Aktiengeshellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Aktiengeshellschaft filed Critical Bayer Aktiengeshellschaft
Publication of EE200300515A publication Critical patent/EE200300515A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EEP200300515A 2001-04-19 2002-04-08 Arüülsulfoonamiidid kui viirusevastased ained EE200300515A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
EE200300515A true EE200300515A (et) 2004-02-16

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300515A EE200300515A (et) 2001-04-19 2002-04-08 Arüülsulfoonamiidid kui viirusevastased ained

Country Status (20)

Country Link
US (1) US7115612B2 (et)
EP (1) EP1383749B1 (et)
JP (1) JP4480941B2 (et)
CN (1) CN1516695A (et)
AT (1) ATE308529T1 (et)
BG (1) BG108272A (et)
BR (1) BR0209054A (et)
CA (1) CA2444123C (et)
DE (1) DE50204780D1 (et)
EE (1) EE200300515A (et)
ES (1) ES2252455T3 (et)
HU (1) HUP0303813A3 (et)
IL (1) IL158324A0 (et)
MX (1) MXPA03009548A (et)
NO (1) NO20034667L (et)
PL (1) PL363990A1 (et)
RU (1) RU2003133750A (et)
SK (1) SK12662003A3 (et)
UY (1) UY27263A1 (et)
WO (1) WO2002085869A1 (et)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006501312A (ja) * 2002-08-23 2006-01-12 ライジェル ファーマシューティカルズ, インコーポレイテッド Hcv感染を治療または予防するのに有用なピリジル置換複素環
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
ES2887054T3 (es) 2003-04-11 2021-12-21 Ptc Therapeutics Inc Compuesto de ácido 1,2,4-oxadiazol benzoico y su uso para la supresión sin sentido y el tratamiento de enfermedades
DE102006009928A1 (de) * 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
IN2014CN04406A (et) 2006-03-30 2015-09-04 Ptc Therapeutics Inc
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
EP2176249A2 (en) * 2007-07-02 2010-04-21 Boehringer Ingelheim International GmbH New chemical compounds
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
CA2803695A1 (en) * 2010-06-28 2012-01-05 Bayer Intellectual Property Gmbh Heteroaryl-substituted pyridine compounds for use as pesticides
WO2012007836A1 (en) 2010-07-16 2012-01-19 Purdue Pharma .Lp. Pyridine compounds as sodium channel blockers
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
JP6482466B2 (ja) * 2012-11-03 2019-03-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング サイトメガロウイルスの阻害剤
US9334249B2 (en) 2012-11-03 2016-05-10 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
WO2015134711A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
WO2016128541A1 (en) * 2015-02-13 2016-08-18 Azienda Ospedaliera Universitaria Senese Human helicase ddx3 inhibitors as therapeutic agents
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法
CN120136858A (zh) * 2017-03-31 2025-06-13 中美博瑞纳制药有限公司 可用作alcat1抑制剂的化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) * 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
KR20010113820A (ko) * 1999-04-19 2001-12-28 시오노 요시히코 옥사디아졸 고리를 갖는 술폰아미드 유도체

Also Published As

Publication number Publication date
JP4480941B2 (ja) 2010-06-16
CA2444123C (en) 2010-09-21
CN1516695A (zh) 2004-07-28
HUP0303813A3 (en) 2005-05-30
IL158324A0 (en) 2004-05-12
ATE308529T1 (de) 2005-11-15
US20040176374A1 (en) 2004-09-09
EP1383749A1 (de) 2004-01-28
US7115612B2 (en) 2006-10-03
CA2444123A1 (en) 2002-10-31
JP2004531536A (ja) 2004-10-14
NO20034667D0 (no) 2003-10-17
PL363990A1 (en) 2004-11-29
HUP0303813A2 (hu) 2004-03-29
BR0209054A (pt) 2004-04-20
WO2002085869A1 (de) 2002-10-31
BG108272A (bg) 2004-10-29
DE50204780D1 (de) 2005-12-08
RU2003133750A (ru) 2005-05-10
NO20034667L (no) 2003-12-12
SK12662003A3 (sk) 2004-04-06
UY27263A1 (es) 2002-11-29
ES2252455T3 (es) 2006-05-16
MXPA03009548A (es) 2004-05-24
EP1383749B1 (de) 2005-11-02

Similar Documents

Publication Publication Date Title
EE200300437A (et) Triasolopüridiinid kui põletikuvastased ained
EE200300515A (et) Arüülsulfoonamiidid kui viirusevastased ained
DE60318769D1 (de) Maskenüberzug
NO20034176D0 (no) Pyrazolopyrimidiner som terapeutiske midler
NO20034177L (no) Pyrazolopyrimidiner som terapeutiske midler
DE60216265D1 (de) Verbesserungen in spritzenhalterungen
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
NO20033205D0 (no) Terapeutiske kromanforbindelser
DK1751161T3 (da) Antivirale diazaindol-dicarbonyl-piperazinyl-midler
NO20014597D0 (no) Fremgangsmåte
NO20041066L (no) Hydroksyeikosensyre-analoger
EA200401429A1 (ru) Баня
IS7943A (is) Ný amínóbensófenónefnasambönd
DE60131852D1 (de) Sprühgerät
ATA11822001A (de) Gerätekonstruktion
DE10291166D2 (de) Anti-Schuppen-Mittel
FR2836809B1 (fr) Baignoire
PT102660B (pt) Novos agentes quelantes polidentados do tipo 3-hidroxi-4-piridinona
SE0103855D0 (sv) Therapeutic agents
SE0103854D0 (sv) Therapeutic agents
UA6364S (uk) Ванна бальнеологічна
SE0101435D0 (sv) Huvudskydd
NO20011527D0 (no) Spann
SE0203826D0 (sv) Therapeutic agents
SE0200450D0 (sv) Therapeutic agents

Legal Events

Date Code Title Description
HK1A Erratum in gazette